Literature DB >> 28470400

Comparative radiological pathological study of biliary intraductal tubulopapillary neoplasm and biliary intraductal papillary mucinous neoplasm.

Chia-Hung Wu1,2, Yi-Chen Yeh3,2, Yu-Chuan Tsuei2,4, Li-Kuo Huang2,5, Chia-I Lin6, Chien-An Liu1,2, Hsiou-Shan Tseng1,2, Yi-You Chiou1,2, Nai-Chi Chiu7,8.   

Abstract

PURPOSE: Biliary tract intraductal tubulopapillary neoplasms (BT-ITPNs) and intraductal papillary mucinous neoplasms (BT-IPMNs) are rare and poorly described. Herein, we examined the magnetic resonance imaging (MRI) features of BT-ITPNs and BT-IPMNs and correlated them with key gross and microscopic pathological findings.
METHODS: We retrospectively identified five patients with definitive pathological findings of BT-ITPN and available diagnostic MRI findings. Key MRI features were correlated to the gross and microscopic pathology and compared to those of BT-IPMNs (19 patients).
RESULTS: All BT-ITPNs showed ductal dilatation and visible intraductal soft tissue with peribiliary liver parenchyma enhancement. One BT-ITPN patient had synchronous lung metastases, and another showed rapid tumor growth rate. The intraductal soft tissue proportion of BT-ITPNs was significantly more than that of BT-IPMNs (p < 0.05). CA-199 level was elevated in 60% of BT-ITPN cases. The overall combined 1-year and 3-year survival rates in the BT-ITPN group was 100% and 40%, and in the BT-IPMN group was 100% and 58%, respectively. A high intraductal soft tissue proportion, a lack of intraluminal mucin, and immunohistochemical absence of MUC5AC are radiological and pathological characteristics that differentiate BT-ITPN from BT-IPMN.
CONCLUSIONS: Although rare, BT-ITPN should be suspected when solid intraductal soft tissue and peribiliary liver parenchyma enhancement are present, particularly if the bile duct upstream and downstream of the lesion have a normal diameter, without mucin. Owing to the aggressive nature of the tumor, recognition of these features may indicate the need for more aggressive treatment in selected patients.

Entities:  

Keywords:  Bile duct; Biliary intraductal papillary mucinous neoplasm; Biliary intraductal tubulopapillary neoplasm; MUC5AC; Magnetic resonance imaging

Mesh:

Year:  2017        PMID: 28470400     DOI: 10.1007/s00261-017-1167-7

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  6 in total

1.  Mucin-producing Cystic Hepatobiliary Neoplasms: Updated Nomenclature and Clinical, Pathologic, and Imaging Features.

Authors:  Matthew H Lee; Venkata S Katabathina; Meghan G Lubner; Hardik U Shah; Srinivasa R Prasad; Kristina A Matkowskyj; Perry J Pickhardt
Journal:  Radiographics       Date:  2021-10       Impact factor: 6.312

Review 2.  Cystic biliary tumors of the liver: diagnostic criteria and common pitfalls.

Authors:  Susan Shyu; Aatur D Singhi
Journal:  Hum Pathol       Date:  2020-12-28       Impact factor: 3.526

3.  Intraductal papillary neoplasm of the bile duct: a single-center retrospective study.

Authors:  Xin Wu; Binglu Li; Chaoji Zheng; Xiaoyan Chang; Taiping Zhang; Xiaodong He; Yupei Zhao
Journal:  J Int Med Res       Date:  2018-08-15       Impact factor: 1.671

4.  Balloon Extraction of an Intraductal Tubulopapillary Neoplasm of the Bile Duct During Endoscopic Retrograde Cholangiopancreatography.

Authors:  Matthew J Sullivan; Jillian Grau; Shashin Shah
Journal:  ACG Case Rep J       Date:  2020-11-24

5.  Intraductal tubulopapillary neoplasms of the pancreas and biliary tract: The black swan of hepatobiliary surgery.

Authors:  Jilyan Decker; Amanda Cavanaugh; Megan Brown; Saverio Ligato; Oscar Kenneth Serrano
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-11-30

6.  Magnetic Resonance Imaging versus Computed Tomography for Biliary Tract Intraductal Papillary Mucinous Neoplasm (BT-IPMN): A Diagnostic Performance Analysis.

Authors:  Jing Li; Yuanlin Yu; Lulong Zhu; Yuping Li; Qing He
Journal:  Med Sci Monit       Date:  2020-04-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.